JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257168

Human LOXL2 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

LOXL2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 4.
6 Images
Western blot - Human LOXL2 knockout HeLa cell lysate (AB257168)
  • WB

Lab

Western blot - Human LOXL2 knockout HeLa cell lysate (AB257168)

Lane 1 : Wild-type HeLa cell lysate (20 μg)

Lane 2 : LOXL2 knockout HeLa cell lysate (20 μg)

Lane 3 : HeLa treated with 0.5nM CoCl2 for 6 hours whole cell lysate (20 μg)

Lane 4 : Untreated HeLa cell lysate (20 μg)

Lanes 1-4 : Merged signal (red and green). Green - ab179810 observed at 105 kDa. Red - loading control, ab8245 observed at 37 kDa.

ab179810 Anti-LOXL2 antibody [EPR12733] - C-terminal was shown to specifically react with LOXL2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab261804 (knockout cell lysate ab257168) was used. Wild-type and LOXL2 knockout samples were subjected to SDS-PAGE. ab179810 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-LOXL2 antibody [EPR12733] - C-terminal (<a href='/en-us/products/primary-antibodies/loxl2-antibody-epr12733-c-terminal-ab179810'>ab179810</a>) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

LOXL2 knockout HeLa cell lysate at 20 µg

Lane 4:

Untreated HeLa cell lysate at 20 µg

Predicted band size: 87 kDa

Observed band size: 105 kDa

false

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)
  • Sanger seq

Unknown

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)

Allele-1 : 1 bp insertion in exon 4

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)
  • Sanger seq

Unknown

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)

Allele-4 :

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)
  • Sanger seq

Unknown

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)

Allele-3 :

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)
  • Sanger seq

Unknown

Sanger Sequencing - Human LOXL2 knockout HeLa cell lysate (AB257168)

Allele-2 :

Western blot - Human LOXL2 knockout HeLa cell lysate (AB257168)
  • WB

Supplier Data

Western blot - Human LOXL2 knockout HeLa cell lysate (AB257168)

Blocking and diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of TBS Negative control : MCF7 (PMID : 19330836). Lysates at 20 µg per lane. The samples were run on a Bis-Tris gel under reducing conditions. Western blot : Anti-LOXL2 antibody (ab314140) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab314140 was shown to bind specifically to LOXL2. Target of interest was observed at 87 kDa in wild-type HeLa cell lysates (lane 1) with no signal observed at this size in LOXL2 knockout cell line (lane 2, knockout cell line ab261804 / knockout cell lysate ab257168). To generate this image, samples were first run on an SDS-PAGE gel then transferred onto an immobilon-FL PVDF membrane.  Membranes were blocked in a fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C.  Blots were washed in TBS-T, incubated with secondary antibodies Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution for 1 h at room temperature, washed again then imaged.

All lanes:

Western blot - Anti-LOXL2 antibody [EPR28298-7] (<a href='/en-us/products/primary-antibodies/loxl2-antibody-epr28298-7-ab314140'>ab314140</a>) at 1/1000 dilution

Lane 1:

Wild-type HeLa whole cell lysate at 20 µg

Lane 2:

Western blot - Human LOXL2 knockout HeLa cell lysate (ab257168) at 20 µg

Lane 3:

MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG H&L (800CW) and Goat Anti-Mouse IgG H&L (680RD) at 1/20000 dilution

Observed band size: 87 kDa

false

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 4.

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257168-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LOXL2 knockout HeLa cell lysate", "number":"AB257168-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB257168-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LOXL2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com